Puma Biotechnology Soars After Positive Briefing Documents By FDA For Neratinib By: TalkMarkets May 22, 2017 at 20:21 PM EDT Puma Biotechnology stock soars 50% on release of positive briefing docs but analysts still warn that approval is no sure thing. Read More >> Related Stocks: Puma Biotechnology